{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:36:59Z","timestamp":1790426219058,"version":"4.1.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T00:00:00Z","timestamp":1733788800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["PJ533"],"award-info":[{"award-number":["PJ533"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/R009635\/1"],"award-info":[{"award-number":["MR\/R009635\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jaip.2024.12.003","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T12:29:22Z","timestamp":1734006562000},"page":"594-609.e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Prospective Piperacillin Lymphocyte Transformation Testing in Patients With Cystic Fibrosis Receiving Regular and Desensitization Courses of Piperacillin-Tazobactam"],"prefix":"10.1016","volume":"13","author":[{"given":"Paul","family":"Whitaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey","family":"Gillgrass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Peckham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean John","family":"Naisbitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2024.12.003_bib1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ppul.10127","article-title":"Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis","volume":"34","author":"Emerson","year":"2002","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jaip.2024.12.003_bib2","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1067\/mpd.2001.112897","article-title":"Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis","volume":"138","author":"Nixon","year":"2001","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2024.12.003_bib3","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/thx.2004.027953","article-title":"Antibiotic allergy in cystic fibrosis","volume":"60","author":"Parmar","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.jaip.2024.12.003_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1440-1754.1998.00197.x","article-title":"Antibiotic hypersensitivity reactions in cystic fibrosis","volume":"34","author":"Wills","year":"1998","journal-title":"J\u00a0Paediatr Child Health"},{"key":"10.1016\/j.jaip.2024.12.003_bib5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1378\/chest.106.4.1124","article-title":"Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis","volume":"106","author":"Pleasants","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.jaip.2024.12.003_bib6","doi-asserted-by":"crossref","first-page":"S608","DOI":"10.1093\/clinids\/13.Supplement_7.S608","article-title":"Retrospective clinical study of hypersensitivity reactions to aztreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple treatment courses","volume":"13","author":"Koch","year":"1991","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.jaip.2024.12.003_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/ACI.0b013e328355b849","article-title":"Nonimmediate beta-lactam reactions in patients with cystic fibrosis","volume":"12","author":"Whitaker","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.12.003_bib8","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/all.13418","article-title":"Identification of T-cell epitopes from benzylpenicillin conjugated to human serum albumin and implication in penicillin allergy","volume":"73","author":"Azoury","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.12.003_bib9","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1124\/jpet.111.190900","article-title":"Characterization of the antigen specificity of T-cell clones from piperacillin-hypersensitive patients with cystic fibrosis","volume":"341","author":"El-Ghaiesh","year":"2012","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.jaip.2024.12.003_bib10","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0300-483X(95)03253-C","article-title":"T\u00a0cell immune responses to haptens. Structural models for allergic and autoimmune reactions","volume":"107","author":"Weltzien","year":"1996","journal-title":"Toxicology"},{"key":"10.1016\/j.jaip.2024.12.003_bib11","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.4049\/jimmunol.157.3.1071","article-title":"Cross-reactivity of T cell lines and clones to beta-lactam antibiotics","volume":"157","author":"Mauri-Hellweg","year":"1996","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.12.003_bib12","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.4049\/jimmunol.155.5.2670","article-title":"Heterogeneous T-cell responses to beta-lactam-modified self structures are observed in penicillin-allergic individuals","volume":"155","author":"Brander","year":"1995","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.12.003_bib13","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1034\/j.1398-9995.2001.000115.x","article-title":"In\u00a0vitro T-cell responses to beta-lactam drugs in immediate and nonimmediate allergic reactions","volume":"56","author":"Luque","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.12.003_bib14","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jcf.2011.02.002","article-title":"Rapid desensitization for non-immediate reactions in patients with cystic fibrosis","volume":"10","author":"Whitaker","year":"2011","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jaip.2024.12.003_bib15","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/j.jaip.2020.12.051","article-title":"Piperacillin-tazobactam hypersensitivity: a large, multicenter analysis","volume":"9","author":"Casimir-Brown","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.12.003_bib16","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.jaci.2010.12.1119","article-title":"Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis","volume":"127","author":"Elsheikh","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.12.003_bib17","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/j.1398-9995.2004.00547.x","article-title":"The lymphocyte transformation test in the diagnosis of drug hypersensitivity","volume":"59","author":"Pichler","year":"2004","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.12.003_bib18","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2222.1997.tb00690.x","article-title":"The lymphocyte transformation test for the diagnosis of drug allergy: sensitivity and specificity","volume":"27","author":"Nyfeler","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.12.003_bib19","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.anai.2022.06.014","article-title":"Lymphocyte transformation test for drug allergy detection: when does it work?","volume":"129","author":"Glassner","year":"2022","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.12.003_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113072","article-title":"Future perspectives on in-vitro diagnosis of drug allergy by the lymphocyte transformation test","volume":"495","author":"Fatangare","year":"2021","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jaip.2024.12.003_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2021.113036","article-title":"Lymphocyte transformation test: history and current approaches","volume":"493","author":"Sachs","year":"2021","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jaip.2024.12.003_bib22","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4049\/jimmunol.1100647","article-title":"Mass spectrometric characterization of circulating and functional antigens derived from piperacillin in patients with cystic fibrosis","volume":"187","author":"Whitaker","year":"2011","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.12.003_bib23","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jcf.2023.12.003","article-title":"Lymphocyte transformation tests predict delayed-type allergy to piperacillin\/tazobactam in patients with cystic fibrosis","volume":"23","author":"Roehmel","year":"2024","journal-title":"J\u00a0Cyst Fibros"},{"key":"10.1016\/j.jaip.2024.12.003_bib24","article-title":"Tools to improve the diagnosis and management of T-cell mediated adverse drug reactions","volume":"9","author":"Copaescu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.jaip.2024.12.003_bib25","article-title":"An updated review of the diagnostic methods in delayed drug hypersensitivity","volume":"11","author":"Copaescu","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jaip.2024.12.003_bib26","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1111\/cea.12145","article-title":"In\u00a0vitro drug causality assessment in Stevens-Johnson syndrome - alternatives for lymphocyte transformation test","volume":"43","author":"Porebski","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.12.003_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2023.113515","article-title":"IFN-gamma secretion of PBMC from non-drug-allergic control persons: considerations for the validity of a positive lymphocyte transformation test","volume":"519","author":"Glassner","year":"2023","journal-title":"J\u00a0Immunol Methods"},{"key":"10.1016\/j.jaip.2024.12.003_bib28","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaci.2017.01.020","article-title":"\u03b2-Lactam hypersensitivity involves expansion of circulating and skin-resident TH22 cells","volume":"141","author":"Sullivan","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.12.003_bib29","doi-asserted-by":"crossref","first-page":"4217","DOI":"10.4049\/jimmunol.1700209","article-title":"Definition of the nature and hapten threshold of the beta-lactam antigen required for T cell activation in\u00a0vitro and in patients","volume":"198","author":"Meng","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.12.003_bib30","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1021\/acs.chemrestox.2c00231","article-title":"Shared clavulanate and tazobactam antigenic determinants activate T-cells from hypersensitive patients","volume":"35","author":"Ariza","year":"2022","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.jaip.2024.12.003_bib31","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/cea.13076","article-title":"Sensitivity and specificity of the lymphocyte transformation test in drug reaction with eosinophilia and systemic symptoms causality assessment","volume":"48","author":"Cabanas","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaip.2024.12.003_bib32","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1111\/j.1398-9995.2007.01553.x","article-title":"Utility of the lymphocyte transformation test in the diagnosis of drug sensitivity: dependence on its timing and the type of drug eruption","volume":"62","author":"Kano","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2024.12.003_bib33","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.jaci.2013.04.048","article-title":"Antigen-specific, antibody-coated, exosome-like nanovesicles deliver suppressor T-cell microRNA-150 to effector T cells to inhibit contact sensitivity","volume":"132","author":"Bryniarski","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.12.003_bib34","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.iac.2021.12.004","article-title":"The who, what, where, when, why, and how of drug desensitization","volume":"42","author":"Yang","year":"2022","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2024.12.003_bib35","article-title":"Allergy evaluation and desensitization standards for radiocontrast media","volume":"37","author":"Jakubovic","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.jaip.2024.12.003_bib36","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.2174\/1381612822666161025154506","article-title":"Desensitization for drug hypersensitivity to chemotherapy and monoclonal antibodies","volume":"22","author":"Bonamichi-Santos","year":"2016","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.jaip.2024.12.003_bib37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S1081-1206(10)61778-4","article-title":"Antibiotic desensitization for the allergic patient: 5 years of experience and practice","volume":"92","author":"Turvey","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2024.12.003_bib38","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000087355","article-title":"Antigen-induced reduction in mast cell and basophil functional responses due to reduced syk protein levels","volume":"138","author":"Kepley","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaip.2024.12.003_bib39","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1084\/jem.20040382","article-title":"Negative regulation of immunoglobulin E\u2013dependent allergic responses by Lyn kinase","volume":"199","author":"Odom","year":"2004","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jaip.2024.12.003_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1083\/jcb.96.1.1","article-title":"Endocytosis and the recycling of plasma membrane","volume":"96","author":"Steinman","year":"1983","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.jaip.2024.12.003_bib41","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jaci.2023.02.009","article-title":"Clonal evolution and stereotyped sequences of human IgE lineages in aeroallergen-specific immunotherapy","volume":"152","author":"Hor","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.12.003_bib42","doi-asserted-by":"crossref","first-page":"709","DOI":"10.4049\/jimmunol.2100485","article-title":"Multistep IgE mast cell desensitization is a dose- and time-dependent process partially regulated by SHIP-1","volume":"210","author":"Adnan","year":"2023","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.12.003_bib43","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jaci.2024.02.017","article-title":"Neutralizing IgG4 antibodies are a biomarker of sustained efficacy after peanut oral immunotherapy","volume":"153","author":"Keswani","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2024.12.003_bib44","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.jaip.2024.02.010","article-title":"Phenotypes of hypersensitivity reactions to pegylated liposomal doxorubicin: safety and efficacy of 128 rapid desensitizations","volume":"12","author":"Turtle","year":"2024","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2024.12.003_bib45","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1172\/JCI87492","article-title":"Mast cell desensitization inhibits calcium flux and aberrantly remodels actin","volume":"126","author":"Ang","year":"2016","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jaip.2024.12.003_bib46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000078583","article-title":"Successful desensitization to fixed drug eruption: the presence of CD25+CD4+ T cells in the epidermis of fixed drug eruption lesions may be involved in the induction of desensitization","volume":"209","author":"Teraki","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.jaip.2024.12.003_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejpn.2007.03.001","article-title":"Phenytoin desensitization monitored by antigen specific T cell response using carboxyfluorescein succinimidyl ester dilution assay","volume":"11","author":"Okumura","year":"2007","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.jaip.2024.12.003_bib48","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.4049\/jimmunol.1602029","article-title":"The effect of inhibitory signals on the priming of drug hapten-specific T cells that express distinct V\u03b2 receptors","volume":"199","author":"Gibson","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jaip.2024.12.003_bib49","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.4049\/jimmunol.1302720","article-title":"Negative regulation by PD-L1 during drug-specific priming of IL-22-secreting T cells and the influence of PD-1 on effector T cell function","volume":"192","author":"Gibson","year":"2014","journal-title":"J\u00a0Immunol"}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824012443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219824012443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:53:10Z","timestamp":1778853190000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219824012443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2213219824012443"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2024.12.003","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prospective Piperacillin Lymphocyte Transformation Testing in Patients With Cystic Fibrosis Receiving Regular and Desensitization Courses of Piperacillin-Tazobactam","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2024.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}